We also observed a higher frequency of tumor-infiltrating CD8 + T cells expressing TNF-α and IFN-γ in the combination treatment group than in the individual anti-TIGIT or RT groups (Fig. 5d). This evidence concerns the gene CD8A and neoplasm.